News
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
20 May 24
News, Intraday Update, Markets, Movers
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
20 May 24
News, Intraday Update, Markets, Movers
Oppenheimer Maintains Outperform on Sutro Biopharma, Maintains $10 Price Target
15 May 24
News, Price Target, Analyst Ratings
Wedbush Reiterates Outperform on Sutro Biopharma, Maintains $8 Price Target
14 May 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Sutro Biopharma, Maintains $12 Price Target
14 May 24
News, Price Target, Reiteration, Analyst Ratings
Sutro Biopharma Q1 2024 Adj EPS $(0.95) Misses $(0.92) Estimate, Sales $13.008M Beat $12.071M Estimate
13 May 24
Earnings, Earnings Beats, Earnings Misses, News
Expert Outlook: Sutro Biopharma Through The Eyes Of 10 Analysts
8 May 24
Analyst Ratings
B of A Securities Initiates Coverage On Sutro Biopharma with Buy Rating, Announces Price Target of $12
8 May 24
News, Price Target, Initiation, Analyst Ratings
Piper Sandler Reiterates Overweight on Sutro Biopharma, Lowers Price Target to $11
3 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Oppenheimer Maintains Outperform on Sutro Biopharma, Maintains $10 Price Target
3 Apr 24
News, Price Target, Analyst Ratings
Truist Securities Maintains Buy on Sutro Biopharma, Lowers Price Target to $18
3 Apr 24
News, Price Target, Analyst Ratings
JMP Securities Reiterates Market Outperform on Sutro Biopharma, Maintains $17 Price Target
3 Apr 24
News, Price Target, Reiteration, Analyst Ratings
What's Going On With Sutro Biopharma (STRO) Stock?
2 Apr 24
News
Ipsen And Sutro Biopharma Enter Exclusive Global Licensing Agreement For An ADC Targeting Solid Tumors
2 Apr 24
News
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
28 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Oppenheimer Maintains Outperform on Sutro Biopharma, Maintains $10 Price Target
28 Mar 24
News, Price Target, Analyst Ratings
Navigating 4 Analyst Ratings For Sutro Biopharma
27 Mar 24
Analyst Ratings
Oppenheimer Maintains Outperform on Sutro Biopharma, Maintains $10 Price Target
27 Mar 24
News, Price Target, Analyst Ratings
Wedbush Maintains Outperform on Sutro Biopharma, Lowers Price Target to $8
26 Mar 24
News, Price Target, Analyst Ratings
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
26 Mar 24
Movers
Press releases
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
13 May 24
Earnings, Press Releases
Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering
2 Apr 24
Press Releases
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
2 Apr 24
News, Contracts, Press Releases
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
25 Mar 24
Earnings, Press Releases